Jiang Qinling, Wei Zhuheng, Liu Pingping, Li Zonghuai, Jiang Huiqin, Cao Yilin, Zhang Bo, Yan Yuanyuan, He Yulong
Department of Oncology, Nanxishan Hospital of the Guangxi Zhuang Autonomous Region, Guilin, China.
Scientific Research Center, Guilin Medical University, Guilin, China.
Front Immunol. 2024 Nov 21;15:1500686. doi: 10.3389/fimmu.2024.1500686. eCollection 2024.
This article aims to analyze the current status and research hotspots of literature related to perioperative management of patients with Lung Cancer and provide reference for future research directions.
This study conducted a bibliometric analysis of research literature related to perioperative management of Lung Cancer published between 2004 and 2024, retrieved from the Web of Science database. R software and VOSviewer were used for analyzing keyword clusters and research themes, revealing trends and frontiers in this field.
A total of 4,942 studies on perioperative management of lung cancer were included. In recent years, research in this area has shown a global upward trend, with particular focus on surgical risk assessment, complication prevention, and postoperative management. Perioperative biomarkers before and after surgery have emerged as a central focus due to their impact on diagnosis and treatment. The application of novel therapies, such as targeted drugs and immunotherapy, in perioperative management is also becoming a significant research hotspot. Additionally, China has been a leading contributor to research output in this field, demonstrating strong performance in international collaborations.
Perioperative management is a critical factor influencing the prognosis of Resectable lung cancer patients. Through a systematic analysis of the current status and research hotspots in perioperative management of lung cancer, this study provides valuable references for future clinical practice and research, particularly regarding the integration of novel therapies to optimize patient outcomes.
本文旨在分析肺癌患者围手术期管理相关文献的现状和研究热点,为未来研究方向提供参考。
本研究对2004年至2024年间发表的有关肺癌围手术期管理的研究文献进行文献计量分析,文献从科学网数据库中检索获得。使用R软件和VOSviewer分析关键词聚类和研究主题,揭示该领域的趋势和前沿。
共纳入4942项关于肺癌围手术期管理的研究。近年来,该领域的研究呈全球上升趋势,尤其关注手术风险评估、并发症预防和术后管理。手术前后的围手术期生物标志物因其对诊断和治疗的影响而成为核心关注点。新型疗法,如靶向药物和免疫疗法,在围手术期管理中的应用也正成为一个重要的研究热点。此外,中国一直是该领域研究产出的主要贡献者,在国际合作中表现突出。
围手术期管理是影响可切除肺癌患者预后的关键因素。通过对肺癌围手术期管理的现状和研究热点进行系统分析,本研究为未来临床实践和研究提供了有价值的参考,特别是关于整合新型疗法以优化患者预后方面。